|

Pericoronary Adipocyte Size Gradient

RECRUITINGSponsored by Institute for Clinical and Experimental Medicine
Actively Recruiting
SponsorInstitute for Clinical and Experimental Medicine
Started2023-06-01
Est. completion2028-07-01
Eligibility
Age30 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07360925

Summary

Evaluation of pericoronary adipocyte gradient (PCAT) in relationship with local atherosclerotic changes in a patient undergoing heart transplantation.

Eligibility

Age: 30 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 30-90 years
* Diagnosis of dilatational or ischemic cardiomyopathy
* Patients undergoing heart transplantation in IKEM

Exclusion Criteria:

* Known combined diagnosis of dilatational and ischemic cardiomyopathy
* Arrhythmogenic cardiomyopathy
* Congenital heart defects
* Non-eligibility due to the absence of informed consent

Conditions3

Heart DiseaseHeart FailureHeart Transplantation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.